Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis
Biospace News
-
July 18, 2019
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon CNP in Children with...
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
Phase II
Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)
Phase II
AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic...
Phase II
Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study...
Firstwordpharma News
-
July 8, 2019
0
Phase II
Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on...
Biospace News
-
July 2, 2019
0
Phase II
Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant,...
Biospace News
-
July 1, 2019
0
Phase II
Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its...
Biospace News
-
June 27, 2019
0
Phase II
Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled...
Firstwordpharma News
-
June 27, 2019
0
1
2
3
...
16
Page 1 of 16
- Advertisement -
MOST POPULAR
Xencor Announces Partial Clinical Hold on Phase 1 Study of XmAb14045
February 20, 2019
Japan’s Ministry of Health, Labour and Welfare Approves CSL Behring Immunoglobulins...
March 26, 2019
New Sandoz biosimilar adalimumab data confirms switching from reference biologic has...
June 14, 2019
BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for...
February 26, 2019
Load more
HOT NEWS
Newer Targets
Mapping oesophageal cancer genes leads to new drug targets
Commercial
Epilepsy Society Calls For Urgent Review Of Medicines Supply Chain
Psychiatry
Cannabis Use During Adolescence Increases Risk for Psychotic Symptoms in Young...
Others
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115...
